Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-02-03
1988-07-19
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546335, 546337, 546339, 546341, 546342, 514351, 544158, 544162, 544170, 548341, C07D21355, C07D21357, A61K 3144
Patent
active
047585730
ABSTRACT:
Compounds of the general formula ##STR1## and pharmaceutically acceptable salts thereof have antithrombotic activity. Het represents 1-[1H-imidazolyl], 1-N-morpholinyl or pyridyl. A representative compound is 6-[2-(1H-Imidazol-1-yl)-1-yl-1-[[(4-methoxyphenyl)methoxy]methyl]ethoxy]he xanoic acid.
REFERENCES:
Profft et al., Chem. Abstracts, vol. 55,(5), pp. 4494-f-4496-h (1961).
Fook Lai M.
Manley Paul W.
G. D. Searle & Co.
Grassler Frank P.
Matukaitis Paul D.
Rotman Alan L.
LandOfFree
Heterocyclic group-containing compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic group-containing compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic group-containing compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597455